JP2022512937A5 - - Google Patents
Info
- Publication number
- JP2022512937A5 JP2022512937A5 JP2021524317A JP2021524317A JP2022512937A5 JP 2022512937 A5 JP2022512937 A5 JP 2022512937A5 JP 2021524317 A JP2021524317 A JP 2021524317A JP 2021524317 A JP2021524317 A JP 2021524317A JP 2022512937 A5 JP2022512937 A5 JP 2022512937A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- solid organ
- composition according
- months
- organ transplantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024135834A JP2024161505A (ja) | 2018-11-08 | 2024-08-16 | Ｈｌａ感作患者を脱感作し患者における腎移植を改善するためのクラザキズマブの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862757676P | 2018-11-08 | 2018-11-08 | |
| US62/757,676 | 2018-11-08 | ||
| US201962855988P | 2019-06-01 | 2019-06-01 | |
| US62/855,988 | 2019-06-01 | ||
| PCT/US2019/060622 WO2020097566A1 (en) | 2018-11-08 | 2019-11-08 | Use of clazakizumab to desensitize and improve renal transplantation in hla-sensitized patients |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024135834A Division JP2024161505A (ja) | 2018-11-08 | 2024-08-16 | Ｈｌａ感作患者を脱感作し患者における腎移植を改善するためのクラザキズマブの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512937A JP2022512937A (ja) | 2022-02-07 |
| JP2022512937A5 true JP2022512937A5 (https=) | 2022-11-07 |
Family
ID=70612280
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524317A Pending JP2022512937A (ja) | 2018-11-08 | 2019-11-08 | Ｈｌａ感作患者を脱感作し患者における腎移植を改善するためのクラザキズマブの使用 |
| JP2024135834A Pending JP2024161505A (ja) | 2018-11-08 | 2024-08-16 | Ｈｌａ感作患者を脱感作し患者における腎移植を改善するためのクラザキズマブの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024135834A Pending JP2024161505A (ja) | 2018-11-08 | 2024-08-16 | Ｈｌａ感作患者を脱感作し患者における腎移植を改善するためのクラザキズマブの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210395358A1 (https=) |
| EP (1) | EP3877412A4 (https=) |
| JP (2) | JP2022512937A (https=) |
| KR (1) | KR20210089719A (https=) |
| CN (1) | CN112969711B (https=) |
| AU (1) | AU2019374905A1 (https=) |
| BR (1) | BR112021007633A2 (https=) |
| CA (1) | CA3117386A1 (https=) |
| WO (1) | WO2020097566A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| KR20210106521A (ko) * | 2018-12-20 | 2021-08-30 | 세다르스-신나이 메디칼 센터 | 기관 이식체의 만성 항체 매개된 거부의 치료에서 클라자키주맙 |
| EP4025596A4 (en) * | 2019-09-04 | 2023-09-20 | Cedars-Sinai Medical Center | Use of calcineurin inhibitor free ctla4-ig + anti-il6/il6r for long term immunosuppression in solid organ transplant recipients |
| WO2023282668A2 (ko) | 2021-07-08 | 2023-01-12 | 주식회사 엘지에너지솔루션 | 리튬 이차전지용 양극 슬러리 조성물, 이를 포함하는 양극 및 리튬 이차전지 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| CA1292686C (en) | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
| CA1294215C (en) | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DK2164514T3 (en) | 2007-05-21 | 2017-02-27 | Alderbio Holdings Llc | Antibodies to IL-6 and its use |
| US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| US9452227B2 (en) * | 2008-11-25 | 2016-09-27 | Alderbio Holdings Llc | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
| WO2011044508A1 (en) * | 2009-10-08 | 2011-04-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biomarkers for prognoses of pulmonary diseases |
| CN102740888B (zh) * | 2009-11-24 | 2016-10-12 | 奥尔德生物制药公司 | Il-6抗体及其用途 |
| US20170174760A1 (en) * | 2015-07-24 | 2017-06-22 | Cedars-Sinai Medical Center | Method for treating antibody-mediated rejection post-transplantation |
| EP3612561A1 (en) * | 2017-04-19 | 2020-02-26 | Alexion Pharmaceuticals, Inc. | Efficacy of an anti-c5 antibody in the prevention of antibody mediated rejection in sensitized recipients of a kidney transplant |
-
2019
- 2019-11-08 EP EP19881047.5A patent/EP3877412A4/en active Pending
- 2019-11-08 CN CN201980073394.4A patent/CN112969711B/zh active Active
- 2019-11-08 KR KR1020217017432A patent/KR20210089719A/ko active Pending
- 2019-11-08 US US17/292,025 patent/US20210395358A1/en active Pending
- 2019-11-08 JP JP2021524317A patent/JP2022512937A/ja active Pending
- 2019-11-08 CA CA3117386A patent/CA3117386A1/en active Pending
- 2019-11-08 WO PCT/US2019/060622 patent/WO2020097566A1/en not_active Ceased
- 2019-11-08 AU AU2019374905A patent/AU2019374905A1/en active Pending
- 2019-11-08 BR BR112021007633-6A patent/BR112021007633A2/pt unknown
-
2024
- 2024-08-16 JP JP2024135834A patent/JP2024161505A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7025477B2 (ja) | 関節リウマチを治療するための組成物およびこれを用いる方法 | |
| JP2022512937A5 (https=) | ||
| JP2018515493A5 (https=) | ||
| AU2009285625A1 (en) | Method for treating multiple sclerosis patients with anti-IL2R antibodies | |
| JP2023551559A (ja) | 抗ｃｄ１９併用療法 | |
| CN118591389A (zh) | 使用萨特利珠单抗治疗中枢神经系统（cns）的脱髓鞘疾病 | |
| BR112020021721A2 (pt) | tratamento da dermatite atópica | |
| JP2024016237A (ja) | 活動性好酸球性食道炎を治療する方法 | |
| JP2022514381A5 (https=) | ||
| JP2025148449A (ja) | クローン病を治療する方法に使用するためのミリキズマブ | |
| WO2018215995A1 (en) | Methods for the treatment of chronic pouchitis | |
| JP2024526060A5 (https=) | ||
| CN116322765A (zh) | 用于用奥瑞珠单抗治疗多发性硬化症的方法 | |
| CN115298210A (zh) | 用于治疗慢性移植物抗宿主病的抗体 | |
| KR20250029919A (ko) | 갈렉틴-9를 억제하는 항체를 사용한 혈액학적 악성종양의 치료 | |
| KR102628314B1 (ko) | 화농성 한선염 치료를 위한 범-elr+ cxc 케모카인 항체 | |
| KR102703936B1 (ko) | 과도한 유리형 light를 포함하는 방법 및 치료 | |
| Soman et al. | Pseudallescheria boydii lung infection in an immunocompetent adult, difficulties in diagnosis and management | |
| JP2023075242A (ja) | 再発型の多発性硬化症を治療するための方法 | |
| CN117940161A (zh) | 伊奈利珠单抗及其在治疗或预防IgG4相关疾病中的使用方法 | |
| JP2024521474A (ja) | 皮膚筋炎（ｄｍ）を治療するための抗ｃ５抗体の投与量及び投与 | |
| JP2026513770A (ja) | 抗ｃｔｌａ４抗体を使用して黒色腫を治療する方法 | |
| CN120285174A (zh) | 抗vegf抗体与parp抑制剂联合用于治疗肿瘤 | |
| EP4623004A1 (en) | Dosage regimen of madcam-1 antibody for treatment of non-alcoholic steatohepatitis | |
| WO2025101427A1 (en) | Use of an immunoconjugate for the treatment of endometrial cancer |